全文获取类型
收费全文 | 1595篇 |
免费 | 80篇 |
国内免费 | 16篇 |
专业分类
耳鼻咽喉 | 35篇 |
儿科学 | 59篇 |
妇产科学 | 64篇 |
基础医学 | 151篇 |
口腔科学 | 32篇 |
临床医学 | 143篇 |
内科学 | 442篇 |
皮肤病学 | 44篇 |
神经病学 | 76篇 |
特种医学 | 79篇 |
外科学 | 319篇 |
综合类 | 27篇 |
一般理论 | 1篇 |
预防医学 | 35篇 |
眼科学 | 47篇 |
药学 | 56篇 |
中国医学 | 4篇 |
肿瘤学 | 77篇 |
出版年
2023年 | 8篇 |
2022年 | 20篇 |
2021年 | 33篇 |
2020年 | 26篇 |
2019年 | 36篇 |
2018年 | 46篇 |
2017年 | 39篇 |
2016年 | 56篇 |
2015年 | 64篇 |
2014年 | 100篇 |
2013年 | 125篇 |
2012年 | 154篇 |
2011年 | 118篇 |
2010年 | 70篇 |
2009年 | 47篇 |
2008年 | 92篇 |
2007年 | 103篇 |
2006年 | 90篇 |
2005年 | 98篇 |
2004年 | 88篇 |
2003年 | 83篇 |
2002年 | 50篇 |
2001年 | 19篇 |
2000年 | 15篇 |
1999年 | 8篇 |
1998年 | 6篇 |
1997年 | 5篇 |
1996年 | 9篇 |
1995年 | 5篇 |
1994年 | 4篇 |
1993年 | 7篇 |
1992年 | 3篇 |
1990年 | 5篇 |
1989年 | 6篇 |
1988年 | 8篇 |
1987年 | 6篇 |
1986年 | 4篇 |
1985年 | 6篇 |
1984年 | 5篇 |
1983年 | 2篇 |
1978年 | 1篇 |
1975年 | 1篇 |
1974年 | 2篇 |
1972年 | 2篇 |
1971年 | 3篇 |
1970年 | 5篇 |
1967年 | 1篇 |
1966年 | 1篇 |
1959年 | 1篇 |
1937年 | 1篇 |
排序方式: 共有1691条查询结果,搜索用时 171 毫秒
41.
B. Baran M. Gulluoglu O. M. Soyer A. C. Ormeci S. Gokturk S. Evirgen S. Yesil F. Akyuz C. Karaca K. Demir S. Kaymakoglu F. Besisik 《Journal of viral hepatitis》2014,21(2):111-120
Chronic hepatitis C (CHC) patients with treatment failure (TF) remain at risk of continuing fibrosis progression. However, it has not been investigated whether there is an increased risk of accelerated fibrosis progression after failed interferon‐based therapy. We aimed to investigate long‐term influence of TF on fibrosis progression compared with untreated patients with CHC. We studied 125 patients with CHC who underwent paired liver biopsies from 1994 to 2012. Patients with advanced fibrosis were excluded from the analysis. Sixty‐three patients had TF, and 62 patients were treatment‐naïve (TN). Annual fibrosis progression rate (FPR) was calculated, and significant fibrosis progression (SFP) was defined as ≥2 stage increase in fibrosis during follow‐up. Multiple regression analyses were performed to find out independent predictors of FPR and SFP. Demographic characteristics and duration between paired liver biopsies were similar in TF and TN groups. Baseline alanine aminotransferase and gamma‐glutamyl transferase (GGT) levels (71 ± 31 vs 47 ± 22, P < 0.001 and 49 ± 39 vs 36 ± 28, P = 0.027, respectively), baseline mean fibrosis stage (2.2 ± 0.7 vs 1.9 ± 0.7, P = 0.018) and histologic activity index (6.3 ± 1.9 vs 4.3 ± 1.6, P < 0.001) were higher in the TF group compared with the TN group. In regression analyses, the strongest independent predictor of fibrosis progression was the GGT level (OR: 1.03, 95%CI 1.01–1.5, P < 0.001). Treatment experience (OR: 5.97, 95%CI 1.81–19.7, P = 0.003) also appeared as an independent predictor of both FPR and SFP. Failed interferon‐based CHC treatment may lead to accelerated FPR in the long‐term compared with the natural course. 相似文献
42.
43.
44.
45.
46.
Hasiloglu ZI Albayram S Tasmali K Erer B Selcuk H Islak C 《Rheumatology international》2012,32(3):805-807
Sjögren’s syndrome is primarily a chronic systemic autoimmune disease that affects exocrine organs. Neurologic symptoms frequently present as peripheral neuropathy due to small vessel vasculitis. Type and prevalence of central nervous system involvement are still controversial. In this report, we present a 35-year-old woman with primary Sjögren’s syndrome with central nervous system vasculitic involvement. 相似文献
47.
Karabag T Aydin M Barut F Buyukates M Dogan SM Celik O Sayin MR 《Texas Heart Institute journal / from the Texas Heart Institute of St. Luke's Episcopal Hospital, Texas Children's Hospital》2012,39(1):116-118
Lymphomatoid granulomatosis is a rare, diffuse, large B-cell lymphoma that is positive for Epstein-Barr virus. A multiorgan process, it manifests itself chiefly in the lungs but can also affect the skin, nervous system, and kidneys. Cardiac involvement and pericardial effusion are very unusual. We report the case of a 62-year-old man with lymphomatoid granulomatosis involving the heart and lungs. Diagnosis was confirmed with wedge biopsy at pericardiotomy, and the patient was treated with cyclophosphamide, prednisolone, and vincristine. Although the patient was still symptomatic at 6-month follow-up, he was in partial remission with improved functional capacity. 相似文献
48.
49.
50.
Mutlu H Berk V Karaca H Erden A Aslan T Akca Z 《Clinical and applied thrombosis/hemostasis》2012,18(5):546-548
The risk of thromboemboli is increased in patients with cancer, and this is precipitated by the chemotherapeutic agents. Bevacizumab is an anti-vascular endothelial growth factor monoclonal antibody and has an importance in the treatment of metastatic colon cancer. The association between bevacizumab, which is demonstrated to increase the risk of thromboemboli, and mean platelet volume (MPV), which is a marker of thrombocyte function, has been investigated within study. A total of 74 patients with metastatic colon cancer were included in the study and the levels of platelets (PLTs), MPV, and platecrit (PCT) values were recorded in SPSS 16.0 program both at baseline and at the >third month. There were significant decreases in 3 parameters (PLT, MPV, and PCT) during the treatment period with bevacizumab (P = .009, P = .001, and P = .000, respectively). Unlike cases with thrombosis, there is a significant decrease in MPV in combination treatments with bevacizumab. 相似文献